George Sigounas named the first-ever chief science advisor at NCI

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

Jason Chiang and Kyung Sung of the Department of Radiological Sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3.2 million, five-year grant from NCI to develop an artificial intelligence-enhanced imaging platform designed to improve yttrium-90 (Y90) radioembolization planning for patients with liver cancer.

June 05, 2026

Vol.52 No.22

Podcast

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

While every agency under HHS, particularly FDA, has seen historic leadership shakeups and massive cuts to personnel and funding over the course of the second Trump administration—NCI has been spared, even getting a small raise, under the direction of NCI Director Anthony Letai.

May 27, 2026

Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer

Top HHS officials last week called for a “moonshot” focused on the role of the microbiome in cancer.

NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing

NCI has been getting what seems to be less austere treatment compared to its NIH counterparts.

USPSTF leaders John Wong and Esa Davis fired by Kennedy, leaving the panel rudderless

Esa M. Davis and John B. Wong have been fired from U.S. Preventive Services Task Force by HHS Secretary Robert F. Kennedy Jr.

May 22, 2026

Vol.52 No.20

By Claire Marie Porter

In Brief

Providence Cancer Institute receives $3.4M NIH grant to study head-and-neck cancer treatments

The Earle A. Chiles Research Institute, a division of the Providence Cancer Institute of Oregon, received an NIH grant for its next phase of treatments for head-and-neck cancers.

May 15, 2026

Vol.52 No.19

George Sigounas named the first-ever chief science advisor at NCI

YOU MAY BE INTERESTED IN

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer

NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing

USPSTF leaders John Wong and Esa Davis fired by Kennedy, leaving the panel rudderless

Providence Cancer Institute receives $3.4M NIH grant to study head-and-neck cancer treatments

Renew today!

Subscriber content

Never miss an issue!

Login